Endast för hälso-och sjukvårdspersonal

Produktresumé för våra godkända läkemedel på FASS:  Breyanzi® (lisokabtagen-maraleucel)

How to become a CAR-T treatment centra

Duration: 5 minutes

MD Renate Galleberg, Haukeland University Hospital Bergen, gives her view on the motivations to improve patient care in aggressive B-cell lymphoma and her lessions from the path to become a CAR-T treatment centra.

Related videos

Biomarkers in LBCL
Optimizing CAR-T Bridging Therapy in LBCL

News

Learn about current topics in hematology, such as new research data, news from events, congresses and more.

Education

Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.

HE-SE 2400028-FEB25 video/ 2009-SE-2500035 01/2026